Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Poet Technologies (POET) Cash & Equivalents: 2016-2025

Historic Cash & Equivalents for Poet Technologies (POET) over the last 10 years, with Sep 2025 value amounting to $13.5 million.

  • Poet Technologies' Cash & Equivalents fell 67.66% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year decrease of 67.66%. This contributed to the annual value of $37.1 million for FY2024, which is 1130.31% up from last year.
  • According to the latest figures from Q3 2025, Poet Technologies' Cash & Equivalents is $13.5 million, which was up 9.30% from $12.4 million recorded in Q2 2025.
  • Poet Technologies' 5-year Cash & Equivalents high stood at $41.8 million for Q3 2024, and its period low was -$4.8 million during Q3 2023.
  • For the 3-year period, Poet Technologies' Cash & Equivalents averaged around $13.2 million, with its median value being $12.4 million (2025).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first slumped by 165.52% in 2022, then soared by 3,044.51% in 2024.
  • Quarterly analysis of 5 years shows Poet Technologies' Cash & Equivalents stood at $14.9 million in 2021, then plummeted by 38.23% to $9.2 million in 2022, then slumped by 67.29% to $3.0 million in 2023, then soared by 1,130.31% to $37.1 million in 2024, then slumped by 67.66% to $13.5 million in 2025.
  • Its Cash & Equivalents stands at $13.5 million for Q3 2025, versus $12.4 million for Q2 2025 and $15.9 million for Q1 2025.